Literature DB >> 1563780

Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.

C A Bate1, J Taverne, J H Playfair.   

Abstract

We have previously shown that malaria parasites liberate exoantigens which, through a phospholipid component, stimulate mouse macrophages to secrete tumor necrosis factor (TNF), which are toxic to D-galactosamine-sensitized mice, and which therefore might be involved in pathology. Plasmodium yoelii exoantigens detoxified by dephosphorylation or digestion with lipases do not induce TNF production. However, these partial structures inhibited its production in response to the exoantigens, although not to bacterial lipopolysaccharide (LPS). When pure phospholipids were tested in a macrophage assay, none stimulated the production of TNF, but phosphatidylinositol (PI) inhibited TNF induction by P. yoelii exoantigens. Moreover, inositol monophosphate (IMP) was the only one of a number of monophosphate saccharides tested which was inhibitory; inositol was not. Macrophages pretreated with PI, IMP, or detoxified exoantigens and then incubated with parasite exoantigens also yielded much less TNF. PI, IMP, and lipase-digested exoantigens of P. yoelii similarly inhibited the TNF-inducing activity of exoantigens of the human parasites Plasmodium falciparum and Plasmodium vivax. Neither PI nor IMP diminished TNF production in response to LPS, in contrast to a platelet-activating factor antagonist [1-O-hexadecyl-2-acetyl- sn-glycero-3-phospho(N,N,N-trimethyl hexanolamine)] which inhibited both exoantigen- and LPS-induced production of TNF. We conclude that at least two different parts of the molecule are involved in the induction of TNF secretion by parasite exoantigens: one requires the presence of a phosphate bound to inositol, and, since dephosphorylated exoantigens were also inhibitory, one does not. It would seem that both affect interactions between parasite-derived exoantigens and the macrophage receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563780      PMCID: PMC257091          DOI: 10.1128/iai.60.5.1894-1901.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  The malaria vaccine: anti-parasite or anti-disease?

Authors:  J H Playfair; J Taverne; C A Bate; J B de Souza
Journal:  Immunol Today       Date:  1990-01

2.  Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils.

Authors:  T Kodama; M Freeman; L Rohrer; J Zabrecky; P Matsudaira; M Krieger
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

3.  Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages.

Authors:  K Nishikawa; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

4.  Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1980-12

5.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

6.  Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X.

Authors:  H Aschauer; A Grob; J Hildebrandt; E Schuetze; P Stuetz
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

7.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

8.  Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides.

Authors:  M Pollack; A A Raubitschek; J W Larrick
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

9.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

10.  Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

View more
  13 in total

1.  The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways.

Authors:  Hossein Javid; Jahanbakhsh Asadi; Farnaz Zahedi Avval; Amir R Afshari; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

2.  Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.

Authors:  N A Sheikh; H N Caro; J Taverne; J H Playfair; T W Rademacher
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin.

Authors:  H N Caro; N A Sheikh; J Taverne; J H Playfair; T W Rademacher
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria.

Authors:  P H Jakobsen; S D Morris-Jones; L Hviid; T G Theander; M Høier-Madsen; R A Bayoumi; B M Greenwood
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

6.  Characterization and purification of a mycoplasma membrane-derived macrophage-activating factor.

Authors:  S Caplan; R Gallily; Y Barenholz
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

7.  Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.

Authors:  P H Jakobsen; V McKay; S D Morris-Jones; W McGuire; M B van Hensbroek; S Meisner; K Bendtzen; I Schousboe; I C Bygbjerg; B M Greenwood
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  Phospholipid-containing toxic malaria antigens induce hypoglycaemia.

Authors:  K Taylor; C A Bate; R E Carr; G A Butcher; J Taverne; J H Playfair
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Signal transduction pathways involved in tumour necrosis factor secretion by Plasmodium falciparum-stimulated human monocytes.

Authors:  S Picot; I Sheick; A Sylvi; A Donadille; P Ambroise-Thomas
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

10.  Stimulators of tumour necrosis factor production released by damaged erythrocytes.

Authors:  C A Bate; D P Kwiatkowski
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.